Disco Pharmaceuticals
Business Services · Germany · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Gottfried-hagen-str. 60 62, Koeln, North...Website
www.discopharma.deRevenue
$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Disco Pharmaceuticals
Founded in 2022 and headquartered in Cologne, Germany, DISCO’s pioneering surfaceome mapping platform transforms the current approach of target discovery for large molecule R&D. The technology identifies proteins and protein communities across the entire cancer cell surface in a scalable manner, thus addressing the need for target candidates for both mono- and bi-specific antibodies.Explore more
Popular SearchesDISCO Pharmaceuticals GmbHDISCO PharmaceuticalsSIC Code 87,873NAICS Code 54,541Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Disco Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Disco Pharmaceuticals is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Disco Pharmaceuticals
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Disco Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Disco Pharmaceuticals has new funding data
Website visits: Recent activity has been detected on your website
Disco Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Disco Pharmaceuticals recently announced quarterly report
Click to see if Disco Pharmaceuticals had a recent Job posting/layoffs
Product Launch: Get notified when Disco Pharmaceuticals launches new products
Recommended Actions
Reach out to Masked Content who joined Disco Pharmaceuticals as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Disco Pharmaceuticals is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Disco Pharmaceuticals is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Disco Pharmaceuticals.
Disco Pharmaceuticals financials insights
Gather financial insights about Disco Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Angel/Seed
$21.7M
Angel/Seed
$21.7M
Disco Pharmaceuticals Tech Stack
A closer look at the technologies used by Disco Pharmaceuticals
See more technologies
Most Recent Scoops
Partnership
Project
Partnership, Business Development, Intellectual Property, Legal Affairs, Medical Research, Pharmaceuticals
Lateral Move
Executive Move
Executive Moves, Lateral Move
New Hire
Executive Move
Executive Moves, New Hire
Funding
Disco Pharmaceuticals News & Media
DISCO Pharmaceuticals Appoints Mark Manfredi as CEO and Announces Final Close of €36 Million Seed Financing
DISCO Pharmaceuticals appoints biotech leader Mark Manfredi as CEO and raises €36M to advance surfaceome-targeted ADC therapies for hard-to-treat tumors
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Disco Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Founded in 2022 and headquartered in Cologne, Germany, DISCO’s pioneering surfaceome mapping platform transforms the current approach of target discovery for large molecule R&D. The technology identifies proteins and protein communities across the entire cancer cell surface in a scalable manner, thus addressing the need for target candidates for bo... Read More
